CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 30 target
Drug / intervention
Nifedipine cream topical applicationdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00496184
NCT00496184Phase 3Completed
CompareCT.gov

Topical Application of Nifedipine Cream for the Treatment of Vulvar Vestibulitis Syndrome

Western Galilee Hospital-Nahariya·interventional·Posted Jul 4, 2007·Updated May 8, 2008

In Brief

A Phase 3 clinical trial evaluating Nifedipine cream topical application for Vulvar Diseases and 4 related conditions. Completed, enrolled 30 participants across 2 sites.

Detailed Summary

To evaluate the use of topical application of Nifedipine cream for the treatment of Provoked localized Vulvodynia (vestibulitis, vestibulodynia).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVulvar Diseases, Vulvar Pain, Vestibulitis, Vestibulodynia, Vulvodynia
CountriesIsrael
Collaborators--

Timeline

Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 4, 2007
Enrollment StartApr 1, 2006
Primary CompletionOct 1, 2007
Study CompletionMay 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 19.0 years ago

Interventions

Nifedipine cream topical applicationdrug